










ECONOMIC CONSEQUENCES OF  
BIOLOGICAL VARIATION: 







Food and Resource Economics Institute,  










Paper prepared for presentation at the 11th congress of the EAAE 
(European Association of Agricultural Economists), 
‘The Future of Rural Europe in the Global Agri-Food System’, 







Copyright 2005 by Lars Otto.  All rights reserved.  Readers may make 
verbatim copies of this document for non-commercial purposes by any means, 




We present an economic decision support model, based on a Bayesian network, for Mycoplasma
infection in slaughter swine production. The model describes the various risk factors for
Mycoplasma infection and their interactions. This leads to a stochastic determination of the
consequences of productivity factors, and this again results in stochastic economic consequences
when changing the risk factors or engaging in control arrangements. We use the model to calculate
how estimated prevalence and level of Mycoplasma changes when we gather evidence from various
veterinarian examinations, and we show how this inﬂuences the distribution of the economic results
of a change in strategy to ﬁght Mycoplasma.
One result is that the proﬁtability in ﬁghting Mycoplasma alone is questionable, i.e. risky, thus
we must consider the loss of all related diseases in a decision context.
Keywords: Decision support system; Bayesian network; Pig; Mycoplasma
JEL Classiﬁcation: C11, D81, Q12
1 Introduction
Animal health economics is a relative new research discipline devoted to create methods and tools
for decision support when implementing control strategies for animal diseases. Traditionally the
decisions are based on the farmers’, advisors’ or veterinarians’ subjective judgment based on intuition,
on experience and on the assumed or expected economic cost and production beneﬁt of the control
strategy. However, there is a strong need for tools providing a more precise evaluation of the economic
consequences of different control strategies. This article is an attempt to provide such a tool with
emphasis on the economic risk caused by biological variation due to diseases. We have chosen to focus
on one disease, Mycoplasma, in the production of swine for slaughter. Mycoplasma (Mycoplasma
hyopneumoniae) was chosen because the induced pneumonia causes large economic losses in the pig
industry worldwide (Ross 1999). Mycoplasma is the primary agent responsible for enzotic pneumoniae,
but secondary infections such as Actinobacillus pleuropneumoniae, Pasteurella multocidae, and
Streptococcus suis can increase the severity of the disease (Christensen et al. 1999).
Miller et al. (2001) presented a static model for estimating the impact of preventive measures for
Mycoplasma among other diseases. The model estimates the economic impact of disease control in the
production system in an enterprise budgeting approach. Thus, the model does not explicit take into
account the inherent biological uncertainty. The uncertainty follows from sensitivity analysis of changes
in the productivity variables, feed conversion, average daily weight gain and mortality rate. These
productivity factors are treated independent of each other and not as a result of the inherent biological
variability as in our model. Thus the model does not at all focus on the inherent and combined
biological variation.
Otto and Kristensen (2004) developed a static biological model based on biological and
veterinarian knowledge without any economic consideration or calculations. We have used this model
as our starting point for calculation of the economic consequences of Mycoplasma. This enables us to
calculate how biological variability causes economic risk based on a solid biological and veterinarian
model. In the terms of economic theory the biological model can be considered as a description of the
production technology, the production set.
Our aim in this paper is to give a short description of the biological model, and then use the model
to calculate the economic loss due to Mycoplasma. The model includes herd speciﬁc information on
risk factors, herd productivity, and results from various examinations and tests of the herd to determine
the present disease level. The estimated disease level is the basis for a potential strategy for ﬁghting the
disease.
From the biological variation described in the biological part of the model, we use the biological













Figure 1. The structure of the decision model
variables that determine the payment from the slaughterhouse to the farmer, and thus it is through the
biological variability in the productivity variables that payments from the slaughterhouse is turned in to
an uncertain economic consequence, i.e. economic risk for the farmer.
2 Method
The biological model stemming from Otto and Kristensen (2004) is a static Bayesian network
(Jensen 1996, 2001). It describes the relation between the various risk factors and the level of
Mycoplasma that the herd is exposed to as a steady state equilibrium. Thus the model is not intended
for acute outbreak of Mycoplasma. A brief introduction to Bayesian network is given in appendix A.
Input to the model is the state of various risk factors, the available results of veterinary
examinations, and the price and cost of changing control strategies. Some of the factors are easily
accessible like the size of the herd. Some factors are more difﬁcult to collect information for the state, it
might not always be immediately available, or it might be expensive to obtain, i.e. the serological
prevalence, results from post mortem examination. If the state of a variable in the model, is unknown,
then the distribution of the states for that factor is calculated in the model based on the result of the
states for the other factors. Thus missing input is calculated just as if it had been output—the results can
therefore be considered as an estimate of what would have been the result if the particular information
of the state was to be achieved.
The output of the model is probability distributions for the Mycoplasma level, the various
productivity outcomes, and the economic consequences, viewed as conditional probabilities given the
evidence of the factors in the model.
The calculation of the conditional simultaneous probability distribution of the productivity nodes
given the observed evidence was done using the propagating method in the inference engine of the
Hugin system (Hugin Expert A/S 2004). The probability distribution of the contribution margin was
found by simulation of the above mentioned conditional simultaneous distribution in the biological
Bayesian network.
The general structure of the decision support model is shown in ﬁgure 1. The risk factors, the herd
diagnostics, and the choice of control strategy affect the biological variation and the state of the herd.
Changes in the control strategy or in any risk factor will change the biological state of the herd. The
biological state, on the other hand, determines the productivity factors like feed conversion, death rate,and average daily weight gain, which again determines the economic consequences of the chosen
strategy given the state of the various risk factors and diagnostics.
A control strategy is any action with the aim to change the level of the disease. Examples of a
control strategy is medication, vaccination, change of purchase policy of piglets, change of productions
system etc. Short term strategies are strategies where the whole effect is exhausted in the short term,
thus the cost coincide with the effect. For a long term strategy the cost and the effect is separated in
time. Typically the cost is paid in the ﬁrst period and the effects or beneﬁts take place in the following
periods, i.e. we have a typical investment scenario. We shall not deal with the investment perspective in
this article.
3 Use of diagnostics as a basis for decisions
The diagnostics are used to determine the current state of the herd with more precision, forming
the basis for a decision of a control strategy for the disease. After a decision to act is taken, the expected
productivity level following a supposed change of control strategy only depends on the expected state of
the herd. The expected change in control strategy is to remove the disease in order to get a higher
productivity and thereby a higher contribution margin. In this new expected state the levels of the
diagnostics are unknown.
If we are almost certain that a disease is present in the herd and that a change in strategy will
remove the disease and thereby result in higher productivity, the strategy should be changed. If we are
uncertain, we might engage in various examinations to get a more precise diagnosis. If the diagnosis
shows that the herd is healthy, the strategy should not be changed since no disease is to be removed. If
on the other hand a disease is present, a change in control strategy is more certain to remove the disease
and thereby increase productivity. Thus the reason to make a more precise diagnosis is make sure it
actually is a disease that causes the problem of the herd.
To make a diagnosis requires visit by a veterinarian, and often various examinations and laboratory
tests on the herd are conducted—this all involves expenses. We therefore must compare the cost of
making a diagnosis with the expected gain from making a diagnosis followed by a matching change in
strategy. If we make a diagnosis we can save the cost of a control if no diseases is present in the herd.
Thus we shall compare the cost of making a more precise diagnosis with the saved cost of not making a
control in the situation where no disease is found in the herd.
This line of thought is shown in ﬁgure 2. The risk factors R inﬂuences the level of disease S which
inﬂuences productivity P and diagnostics D as shown in ﬁgure 2. The dotted lines in the ﬁgure
originate from the variables that inﬂuence the decisions, whether to change one or more of the risk
variables of whether or not to engage in a control as vaccination or medication, i.e. which action to take.
In the ﬁgure we denote the current state of productivity measured in period 0, the present, by P 0. The
expected state of productivity as a consequence of the control strategy shows in period 1, the future,
denoted by P1. We break up the state of productivity in a base level, normal level, P normal corresponding
to the level of the herd when it is completely free of diseases. The difference between the measured
state and the normal state is the effect on productivity caused by diseases; we denote it
 P = P − Pnormal. The expected change in productivity is then
P1 − P0 = Pnormal +  P1 − (Pnormal +  P0)
=  P1 −  P0 (1)
when we assume that the normal productivity in the absence of disease, P normal, does not change with
control actions. It follows from the equations that we do not need to know the normal productivity to be








P1 = ∆P1 + Pnormal
= ∆P1 + P0 − ∆P0
Pnormal
∆GM = GM1 − GM0
Note: Subscript 0 indicate the date of diagnosis, and 1 is
after the action is taken.
The dashed arrow marked i) is only relevant for an infec-
tious disease when the state of disease not only depends
on the risk factors, but also on whether disease previously
was found in the herd.
Var Text
A Action, make a change, or a control strategy
D Diagnostics, where evidence of the disesase is
obtained
R Risk factors, some are changeable
λ Unknown risk factors, risk factors not included
in the model because we do not know them
S Mycoplasma
P Productivity variables of importance for the
contribution margin
Pnormal Productivity when the herd is free from
diseases. Depends on management and the
general production relations of the herd.
 P Change in productivity due to the disease
compared to the level without the disease.
GM Contribution Margin (proﬁt), the economic
consequences of the control
therefore do not need to consider the size of the unobserved variable P normal. We can use the change in
the productivity variables to calculate the change in the contribution margin. We therefore do not need
to model how the contribution margin as a whole is determined.
There are two relations in the model that can suggest that disease could be a problem in the herd.
The ﬁrst is low productivity and thereby also a low contribution margin. The other is the results from
diagnostic tests. One could argue that there is also a third relation in the model as the level of the risk
factors more or less can indicate that there could be a problem with diseases in the herd; but if neither
productivity nor diagnoses show any sign of a disease there is no need for a change in control unless we
expects that the disease will emerge at a later time—the problem is then whether it pays off to engage in
preventive control. In some countries preventive control is forbidden, i.e. preventive medication is
forbidden in Denmark.
The diagnostics are only used to estimate whether it is worth changing control strategy, i.e. to
estimate how likely it is that the production results from the herd are inﬂuenced by a disease. The
diagnostics are therefore only indirectly used when we estimate the expected state after a change in
control strategy. If the diagnostics tells us that there is a low probability that the productivity is
inﬂuenced by a disease, a change in control with special reference to the disease will be expected to
have a low impact on change in productivity; this is the “explain away aspect” of a diagnosis: it tells us
that it is not disease that is the problem in the herd. The expected effect of a control thus depends on
whether the current state of productivity is inﬂuenced by diseases or not.
A change in control strategy sets a new level for the disease. The new level is independent of the
earlier level, except in the case of an infectious disease, and it depends only on the new level of the risk
factors. The effect of the change in control will on the other hand depend on the diagnose and the risk

































Figure 3. The causal connections in the Bayesian network for the biological model
4 The production set: The biologic part of the model
A detailed description of the biological part of the model can be found in Otto and Kristensen
(2004). To give the reader an impression of the size and complexity of the model, we have shown the
whole causal structure of the biological part of the model in Figure 3 and a detailed description of the
nodes is given in Table 4.
In the top right corner of Figure 3 the nodes representing various risk factors and other conditions
that inﬂuence or are expected to inﬂuence the level of Mycoplasma are kept side by side. They all point
to the node infection pressure that inﬂuences how many animals are infected, the true prevalence, and
how severe the herd is affected, myco severity. The node myco severity again affects the productivity
nodes, daily weight gain, feed conversion, and mortality.
The farmer can affect the distribution of the productivity and thereby the economic outcome by
either changing the risk factors, like take exceptional measures to prevent the pigs from getting infected
at all, or through control strategies like medication or vaccination. To be able to calculate the economic
effect of a changed strategy, we need to know the actual state of the herd, i.e. the state of myco severity.
The more accurate we know the state of myco severity, the more accurate we can determine how
changes in risk factors and control strategies can be expected to change the productivity variables and
thereby change the contribution margin. Part of this knowledge for myco severity is only indirectly
available through various diagnostics and post mortem examination.
5 Calculating economic loss due to Mycoplasma
Animal health economics is just like any other kind of production economics. We have receipts
and expenditure (cost) and the difference is proﬁt and here we focus on the contribution margin. More
precisely we focus on change in the contribution margin caused by changes in the level and severity of
Mycoplasma in the herd. The changes in contribution margin are connected to the productivity nodes,
i.e. changes in feed conversion, changes in daily weight gain, and changes in mortality, and to the
prices, i.e. the prices of the various feed components, labour cost for handling the pigs, wage and hours,
and the price of the pigs delivered for slaughter.
We do not need the model to calculate the level of all the productivity variables or the contribution
margin. We only need to calculate changes due to Mycoplasma from the observed level of the herd as
explained in connection with equation (1). Thus when we calculate the economic consequences ofTable 1. The variables in the biological model
Label Text
all in–all out Only pigs at the same age are housed in a room; when the room is emptied, all pigs are moved out
before cleaning, disinfection and repopulation with pigs at same age. States: yes

no
















change in feed conversion Change in feed conversion due to disease caused by Mycoplasma in the herd. Mea-
























infection pressure The estimated infection pressure due to Mycoplasma in the herd; an aggregate of the risk















myco severity How severe the Mycoplasma infection is within the herd; a statistical latent variable, an aggregate







pleuropneumonia Prevalence of pleuropneumonic lesions observed at slaugther. States: 0–10%

10%–
post-mortem examination The prevalence of pigs with lung lesions due to Mycoplasma infections observed at slaugther,
post-mortem examination—a standard procedure at the slaughterhouse. The distribution of lung




















true prevalence True prevalence of Mycoplasma infected pigs in the herd (the prevalence that would be expected







vaccination Is vaccines against Mycoplasma used within the herd? States: no

yes
medication Is medication against Mycoplasma used within the herd? States: no

yes
region The geographic location of the herd in Denmark. States: The islands

Jutland















toxigenic P. multocida Whether the herd is infected with toxigenic Pasteurella multocida. States: no

yes
veterinary examination The veterinarian’s subjective opinion of the disease in the herd after a clinical examiniation—in






highMycoplasma, we take outset in the actual level observed at the herd, i.e. the actual or observed level of
the productivity variables and the actual or observed level of the contribution margin. This was
explained in connection with Figure 2.
The biological part of the model determines the distribution of the productivity variables and
thereby determines the distribution of the contribution margin. The economic consequences of a new
control strategy is the change in receipts and cost owing to the change in control strategy. It is not the
actual or expected level of receipts and expenditure that are of interest, but the expected changes of the
receipts and expenditure when decisions are made.
When we evaluate the economic consequences of different control strategies, our starting point
must be the characteristics of the speciﬁc herd under examination and not that of an average herd.
Therefore it is important to be able to describe the actual state of the speciﬁc herd because the expected
changes depends on the state of the herd. This is done for nodes relating to
• General risk factors, production system, size of herd, purchase policy etc.
• Herd speciﬁc characteristics, for example results from veterinary examinations, serological
examinations, post mortem examinations etc.
• The starting level for the productivity nodes, i.e. the actual level of daily weight gain, feed
conversion, and death rate.
We calculate the loss due to Mycoplasma as the difference between contribution margin in the herd
and the estimated contribution margin if the herd had no Mycoplasma at all, i.e. the herd was healthy.
The healthy herd is a theoretical construction that we calculate in the model and use as base level. As
we only consider the expected changes in the contribution margin, the base level itself is not part of the
calculations.
The contribution margin is calculated as revenue minus variable cost. The revenue, TR, depends on
the number of pigs sold to the slaughterhouse, their weight and the price per kg.
TR = size · weight · netprice. (2)
The variable cost, VC, depends on the number of porkers bought, the cost of feed, price for
transportation of pigs to slaughter and the cost of handling manure. Also included in the variable cost is
the cost of various examinations and tests carried out and the cost of an possible implemented control
















+ size · other variable cost per pig + size · labout cost per pig
+ cost of diagnoses + cost of control strategy.
The three productivity nodes, the daily average weight gain, mortality, and the feed conversion, and the
variables together with diagnosing and control in the biological network are the nodes that directly
inﬂuence the contribution margin. Thus the simultaneous probability distribution of the productivity
nodes determines the probability distribution of the contribution margin conditional on the evidence in
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Figure 4. Distribution function for economic loss due to Mycoplasma
Table 2. Economic loss due to Mycoplasma (veriﬁed)
DKR per pig Mean 25% Median 75%
1. Healthy herd 6 0 0 12
2. Diseased herd 50 45 52 57




Figure 5. Economic loss due to Mycoplasma (veriﬁed)
6 The maximum loss due to Mycoplasma
If we are certain that there is no Mycoplasma in the herd, we have a healthy herd, we then only
have a loss due to biological variation compared to the maximum contribution margin for at healthy
herd; we use this value as a standard for comparison. The variation for a healthy herd compared to this
standard is shown as a distribution function in ﬁgure 4 marked Healthy herd. The biological variation
says that there is a positive probability of getting a lower contribution margin than the maximum
possible even though the herd is healthy. The probability is nearly 60% of getting a loss less than DKR
0 and almost 100% of getting a loss less than DKR 20.
If we have veriﬁed with certainty that the herd is sick, and thereby a high prevalence and high
severity of Mycoplasma, the distribution of loss due to Mycoplasma is shown in ﬁgure 4 marked
Diseased herd. The probability of a loss less than DKR 20 per pig is 1%, it is nearly 60% of getting a
loss less than DKR 50, and 90% of getting a loss less than DKR 58. The mean and the quartiles of the
distribution for the loss due to Mycoplasma are shown i table 2 and as a box plots in ﬁgure 5.
Unfortunately, we do not always know whether the herd is healthy or sick. The above ﬁgures can
therefore only be considered as upper limits to the economic effects of Mycoplasma.
If we observe a herd with a low contribution margin, it could be due to Mycoplasma, but it could
also have other courses. Thus it might not be proﬁtable to change strategy to control Mycoplasma if
there is no or very little Mycoplasma in the herd. In the case without Mycoplasma we would have the
cost of changing the strategy, but we will get no beneﬁts, since we are ﬁghting a non-present disease.
Thus if we are to change the control strategy to ﬁght Mycoplasma, we most have some indication that
Mycoplasma is present in the herd, and that this causes the low contribution margin. This is where the
clinical and post mortal serological examinations come into play.Table 3. Explanations of the veterinary evidence obtained
Label Text
1 No evidence No evidence is gathered; i.e. no other evidence is available than the
characterization of the risk factors, i.e. high-risk or low-risk herd
2 noSero The prevalence of Mycoplasma infection measured by serological
examination in the herd is zero.
3 highSero The prevalence of Mycoplasma infection as measured by serological
examination in the herd, is high.
4 noUSK The prevalence of pigs with lung lesions due to Mycoplasma infections
observed at slaughter, post-mortem examination, is zero
5 highUSK The prevalence of pigs with lung lesions due to Mycoplasma infections
observed at slaughter, post-mortem examination, is high
6 noSero, noUSK Both the prevalence of Mycoplasma infection measured by serological
examination and with lung lesions due to Mycoplasma infections
observed at slaughter, post-mortem examination, is zero
7 highSero, highUSK Both the prevalence of Mycoplasma infection measured by serological
examination and with lung lesions due to Mycoplasma infections
observed at slaughter, post-mortem examination, is high.
7 Economic consequences based on evidence of Mycoplasma
We now show how the model can be used to decide whether a low contribution margin is caused by
Mycoplasma or caused by another problem in the herd, and thereby whether it can be expected to be
proﬁtable to undertake a control strategy to ﬁght Mycoplasma. Or if the cause of the low contribution
margin should be sought elsewhere.
Neither of the central diagnostic variables in the model (true prevalence and lung lesion) are
directly observable, they can only be observed indirectly being subject to uncertainty through clinical
examination or (more precisely and more expensively and still being subject to uncertainty) through a
serological examination (serological prevalence) and a post-mortem examination. We will therefore
analyze how the results from various examinations inﬂuence our view on the state of health in the herd,
and how again the resulting view inﬂuence our economic valuation of the disease.
We consider two herds with different risk proﬁles: a low-risk herd characterized by all in–all out
production, a small herd size and no buying of piglets from other herds, and a high-risk herd
characterized by not managing all in–all out production, a large herd size and buying piglets from many
other herds.
Before we even enter the pigsty, we have some knowledge of the state of the risk factors, since we
know whether it is a high-risk or a low-risk herd—we just have to talk to the farmer or his adviser to
know this, we do not have to look at the pigs. This is what we call “No evidence” in Table 3. When we
afterwards examine the pigs we gather more evidence as shown in the following rows in the table.
For each herd we ﬁnd that the loss due to Mycoplasma depends on the probability of existence of
the disease in the herd. We consider two examinations: a serological test and a post-mortal examination.
The possible combinations of outcome from the tests are shown in Table 3.
7.1 High-risk herd
For the high-risk herd the mean loss due to Mycoplasma in the herd is shown in Table 4. In the
table we also show the median and the 25% and 75% quartiles. The distribution of the losses areTable 4. The economic loss due to Mycoplasma conditional on veterinary evidence in a high-risk herd
DKR per pig Mean 25% Median 75%
1. No evidence 24 15 19 34
2. noSero 17 7 17 24
3. highSero 38 23 40 52
4. noUSK 19 12 19 26
5. highUSK 42 34 45 52
6. noSero, noUSK 13 0 12 19
7. highSero, highUSK 48 45 52 57









Note: The explanations of the notation in the table can be found in Table 3.









Note: The explanations of the notation in the table can be found in Table 3.
Figure 6. The economic loss due to Mycoplasma conditional on veterinary evidence (sorted by the
median) in a high-risk herd
presented as box plots in the ﬁgure in the right side of the table. The box plots are repeated in Figure 6,
but here the evidence cases are sorted by the median of the loss due to Mycoplasma.
In the state without any veterinary evidence, “No evidence” in Table 4, the mean loss due to
Mycoplasma is DKR 24 per pig, in the column marked 25% we ﬁnd the number 15 showing that there
is a probability of 25% that the loss is less than DKR 15 per pig, and a probability of 25%(= 1 − 75%)
that it is above DKR 34 per pig.
If a veterinary examination in the form of a serological test was done and the result showed a high
level of infection then we would be more certain that Mycoplasma is present in the herd. The mean loss
due to Mycoplasma is now DKR 37, row “highSero” in table 4.
If we also make a post-mortem examination and the result from that show a high level as well then
the evidence is high of Mycoplasma is present in the herd; the mean loss due to Mycoplasma would
then be 48, row “highSero, highUsk” in Table 4. Thus if Mycoplasma could be expelled we would on
average save DKR 48 per pig, meaning that it on average would be proﬁtable to spend up to DKR 48
per pig for a control to get rid of the disease. Note also that if both serological test and post-mortem
examination show that the level of Mycoplasma in the herd is high, besides a high mean loss due to the
disease, the spread in the distribution is smaller, and more narrow, as can be seen from the box plots in
the rigth part of Table 4 and in Figure 6.
7.2 Low-risk herd
The results for the low-risk herds are shown in Table 5 and as box plots in Figure 7.
When we look at a low-risk herd, the mean loss is much less that for the high-risk herd in the caseTable 5. The economic loss due to Mycoplasma condition on veterinary evidence in a low-risk herd
DKR per pig Mean 25% Median 75%
1. No evidence 14 0 12 22
2. noSero 9 0 3 12
3. highSero 26 4 24 46
4. noUSK 9 0 4 13
5. highUSK 35 19 40 52
6. noSero, noUSK 7 0 0 12
7. highSero, highUSK 47 44 52 57









Figure 7. The economic loss due to Mycoplasma condition on veterinary evidence (sorted by the median)
in a low-risk herd
of no evidence. When we gather veterinarian evidence, the difference in loss between the to herds
decrease. This is of course as expected. A low-risk herd has a lower expected Mycoplasma than a
high-risk herd and therefore has a lower expected loss due to Mycoplasma. Thus when we observe a
low-risk herd, the risk factors are dominating over just one veterinary examination, but not over two
examinations. Therefore to diagnose a low-risk herd of Mycoplasma there must be many arguments for
Mycoplasma, and correspondingly we must have many arguments to make a strategy for ﬁghting
Mycoplasma proﬁtable.
8 Economic consequences of control measures
So far we have calculated the loss due to Mycoplasma conditional on results from various
examinations. Now we shall use these numbers to calculate the proﬁtability of control strategies. We
shall only consider two short term control strategies: vaccination and medication. The cost of the
strategies are composed of the price of vaccine and medicine itself plus labour cost distributing it to the
pigs.
The results from the analysis of medication in a high-risk herd are shown in Table 6. The expected
average increase in contribution margin due to a medication strategy conditional on no evidence, is
shown to be DKR −2, i.e. en expected average loss of 2 DKR per pig, on average medication does not
pay off. The last column in the table shows that there is a probability of 56% for a loss if conducting the
medication strategy in this situation. Only if both serology test and post-mortem examination show sign
of high prevalence of Mycoplasma, medication pays off—the expected increase in contribution margin
is DKR 21. Even when we are looking at a high-risk herd we must thus have high evidence that
Mycoplasma is present in the herd for medication to be proﬁtable. But even if we are pretty sure thatTable 6. Change in contribution margin due to medication conditional on veterinary evidence in a high-
risk herd
DKR per pig Mean 25% Median 75% Prob. loss
1. No evidence −2 −15 −31 0 5 6 %
2. highSero 11 −31 32 6 3 0 %
3. highSero, highUSK 21 10 22 33 10%
Table 7. Change in contribution margin due to medication conditional on veterinary evidence in a low-
risk herd
DKR per pig Mean 25% Median 75% Prob. loss
1. No evidence −11 −29 −14 2 72%
2. highSero 1 −16 3 21 47%
3. highSero, highUSK 20 10 22 33 12%
Table 8. Change in contribution margin due to vaccination conditional on veterinary evidence in a high-
risk herd
DKR per pig Mean 25% Median 75% Prob. loss
1. No evidence 3 −10 3 17 46%
2. highSero 17 2 18 33 24%
3. highSero, highUSK 27 14 26 41 6%
Table 9. Change in contribution margin due to vaccination conditional on veterinary evidence in a low-
risk herd
DKR per pig Mean 25% Median 75% Prob. loss
1. No evidence 0 −18 0 15 52%
2. highSero 13 −61 23 3 3 3 %
3. highSero, highUSK 32 18 31 48 6%
Mycoplasma is the problem, a signiﬁcant probability, 10%, still prevails that the medication strategy
will result in a loss.
In the case of a low-risk herd (Table 7) the change in contribution margin is smaller than the
change for the high-risk herd in the case of no or little evidence of Mycoplasma because now the effect
of medication is less, there is probably no Mycoplasma, and the cost is the same. If on the other hand
we are pretty sure that there is Mycoplasma in the herd, both examinations show high evidence of
Mycoplasma, the change in contribution margin is almost the same in the low-risk and high-risk herd.
The results from vaccination in a high-risk herd are shown in Table 8 and for a low-risk herd in
Table 9. The conclusions from this is the same as from medication, one must be rather sure that there is
Mycoplasma in the herd for vaccination to be proﬁtable.
9 Discussion
We have demonstrated that for a herd with a low contribution margin it is important to estimate the
cause. Only if a substantial evidence exists that the cause of the low contribution margin is a disease is
it proﬁtable to ﬁght the disease. Even if risk factors are present it might not be proﬁtable to conductveterinarian examinations to increase the evidence, the cost of the examinations are an essential factor
here.
The problem of making a diagnosis is therefore not just a veterinarian problem, but also an
economic problem. Is it proﬁtable to make a precise diagnosis? The answer is that it is only proﬁtable
to make a precise diagnosis if it will make the action more proﬁtable. If all or most risk factors for a
disease are present and if the contribution margin is low then the probability of a disease in the herd is
high. As the examinations by veterinarians are also subject to uncertainty an examination might not
change the probability of a disease. But examinations are expensive, and if they are not expected to
change the probability of the disease, or only a small change, it might not be proﬁtable to conduct the
examination.
If two veterinarian examinations show different results then typically the spread of the cost is very
large, the uncertainty as to whether there is or there is not Mycoplasma in the herd increases. In the case
where one examination shows zero and another shows high prevalence we can actually get a two modus
distribution, either the prevalence is close to zero or it is high, we cannot say which, but we can say the
prevalence is probably not in the middle—the probability that both are wrong is small.
Even though we have shown that it seldom pays off to ﬁght Mycoplasma, this is not the whole
truth. Most strategies for controlling Mycoplasma also have an impact on other diseases. When we
calculate the proﬁtability of a control strategy, we must therefore take into considerations the beneﬁts
from all the affected diseases and this might make it proﬁtable. For the ﬁgures we have shown for loss
due to Mycoplasma, it will never pay off to ﬁght Mycoplasma with more general and long lasting
control strategy like changing the production system, but if we take the effects from other diseases into
consideration this might change.
Thus we have to consider several diseases and their interactions when we are about to make
decisions on animal health economics.
A Use and interpretation of a Bayesian network
Bayesian networks are discussed in the books by Jensen (1996, 2001). Note that despite the name,
“Bayesian networks” does not imply a commitment to Bayesian methods—but refers instead to the use
of Bayes’s formula for probabilistic calculus.
A Bayesian network is a graphical model where the variables are connected with arrows
corresponding to direct causal relations in the model; in graph theory, the variables also are called
“nodes”. When variable A is the cause of variable B, we have the graph below. When there is an arrow
B A
from A pointing to B, we call A a “parent” of B and B a “child” of A. The parameter in our model is the
conditional probability P(B|A) of B given the state of A.I fA is a factor and B is the variable being sick,
then pyes corresponds to the conditional probability P(B|A), the probability of being sick dependent on
the factor. The Bayesian network is based on Bayes’ formula P(B|A) =
P(A,B)
P(A)
such that when we







. This implies that knowledge about B can help us to infer about A.
Thus, even though the causal connection is in the direction of the arrow, information can ﬂow in the
opposite direction.
When more variables are involved (as in the ﬁgures below), then we say that C is conditionally
independent of A given B. When we have evidence about C, then we can make inference about B and






if we also have evidence about C, this does not change our evidence on A (because all information from
C to A now is blocked by the evidence about B). For the left-hand graph we have
P(A,B,C) = P(C|A,B) P(A,B) = P(C|B) P(B|A) P(A); for the right hand graph,
P(A,B,C) = P(A|B) P(C|B) P(B). For both graphs, evidence on C would give us information on B
and then on A. Evidence about B will block communication between A and C; i.e. new information
about A would not change our information about the probability of C. This is the Markov property of
the Bayesian net.




A fast way to calculate and update the probabilities in a Bayesian network (“propagation” and
“collecting evidence” in the Bayesian-network terminology) is given in the above-mentioned books on
Bayesian networks.
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